Chest Pain News and Research

RSS

New technology shows potential to streamline the analysis of proteins

New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike.

14 Aug 2018

Incidence of coronary artery compression in children may be more common than previously thought

The incidence of coronary artery compression in children fitted with epicardial pacemakers may be slightly more common than previously believed, say noted cardiologists.

13 Aug 2018

New high-sensitivity blood test quickly rules out heart attack in emergency room patients

A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency room was safe and effective, ruling out heart attack in emergency room patients faster than a conventional method, according to new research in the American Heart Association's journal Circulation.

6 Aug 2018

Women having heart attacks experience longer wait time for cardiac intervention

A recent study shows women having heart attacks experience higher than 30% longer wait time from the onset of symptoms to hospital arrival than men and a higher than 20% longer time from hospital arrival to cardiac intervention compared to men.

1 Aug 2018

FDA approves first therapy for patients with rare tumors of the adrenal gland

The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.

31 Jul 2018

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

UCSF Benioff Children's Hospital Oakland clinical researchers, in conjunction with other sickle cell centers and scientists at Emmaus Life Sciences, Inc., have demonstrated that therapy with L-Glutamine reduced the frequency of pain episodes in both pediatric and adult patients with sickle cell disease.

27 Jul 2018

New clinical trial examines use of adrenaline to treat cardiac arrests

A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive - but almost doubles the risk of severe brain damage for survivors of cardiac arrest.

19 Jul 2018

Study finds discharge against medical advice as predictor of readmissions in heart attack patients

In a new study led by Keele University researchers found discharge against medical advice as the strongest predictor of 30-day unplanned readmissions in heart attack patients.

18 Jul 2018

Catheter-based ablation procedure reduces risks of death, stroke in AFib patients

Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the common form of heart arrhythmia known as atrial fibrillation, or AFib, new research from UC Davis physicians shows.

30 Jun 2018

FDA grants approval for new device to treat breathing difficulty caused by severe emphysema

The U.S. Food and Drug Administration today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.

29 Jun 2018

Diagnosing Coronary Heart Disease Using AI

Currently, stress echocardiograms used to diagnose heart disease are only 80% accurate, meaning many patients are misdiagnosed or sent home. Ultromics have developed a tool that uses machine learning to gather data and improve the accuracy of heart disease diagnoses to over 90%.

22 Jun 2018

Study: Effects of atrial fibrillation can be reduced or reversed by losing weight

Australian research shows for the first time that obese people who are suffering from atrial fibrillation can reduce or reverse the effects of the condition by losing weight.

20 Jun 2018

Research explores role of autopsy in cardiovascular medicine

Autopsy is often an overlooked source of medical insight which may be hindering advances in cardiovascular medicine, according to new research published in a special issue of the American Heart Association's journal Circulation.

18 Jun 2018

On-site pathology testing benefits remote Australians and helps save millions

On-site pathology testing is allowing remote Australians to receive effective emergency medical treatment close to home, while saving millions according to researchers.

12 Jun 2018

High-sensitive troponin T detects more cardiac infarctions than conventional ones, shows study

Five percent more cardiac infarctions detected and 11 percent fewer patients suffering a relapse. That is the result of a study of more than 80,000 patients in which two cardiac damage markers were compared with each other.

8 Jun 2018

Synthetic cannabis use may increase risk of heart attack and stroke

The warning follows their treatment of a 25 year old prison inmate who had no family history of heart disease or traditional cardiovascular risk factors, and who was left with a permanent disability.

8 Jun 2018

Patients diagnosed with high-sensitivity troponin test have lower risk of future heart attack

The newer high-sensitivity troponin test discovers smaller amounts of heart-specific proteins, troponins, than the older troponin test and thus identifies more myocardial infarction patients than before.

5 Jun 2018

Genomic medicine may redefine cardiovascular care in future, shows study

A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine -- the study of the health effects of the molecular interactions of a person's unique genes -- for studying cardiovascular traits and disorders and for therapeutic screening.

29 May 2018

PCI along with prescribed drugs better than medication alone for treating for people with heart disease

A non-surgical procedure, called percutaneous coronary intervention, along with prescribed medication, is better than medication alone as initial treatment for people who have the most common form of heart disease, suggests an analysis of an international clinical trial co-led by St. Michael's Hospital.

22 May 2018